Distal arthrogryposis and muscle weakness associated with a β-tropomyosin mutation
Authors:
- 6 March 2007
- journal article
- case report
- Published by Wolters Kluwer Health in Neurology
- Vol. 68 (10) , 772-775
Abstract
Tropomyosin (TM), a sarcomeric thin-filament protein, plays an essential part in muscle contraction by regulating actin–myosin interaction. We describe two patients, a woman and her daughter, with muscle weakness and distal arthrogryposis (DA) type 2B, caused by a heterozygous missense mutation, R133W, in TPM2, the gene encoding β-TM. Our results demonstrate the involvement of muscle dysfunction in the pathogenesis of DA and the fact that DA2B may be caused by mutations in TPM2.Keywords
This publication has 10 references indexed in Scilit:
- Mutations in embryonic myosin heavy chain (MYH3) cause Freeman-Sheldon syndrome and Sheldon-Hall syndromeNature Genetics, 2006
- Myosin storage myopathy associated with a heterozygous missense mutation in MYH7Annals of Neurology, 2003
- Mutations in Genes Encoding Fast-Twitch Contractile Proteins Cause Distal Arthrogryposis SyndromesThe American Journal of Human Genetics, 2003
- Mutations in the β-tropomyosin (TPM2) gene – a rare cause of nemaline myopathyNeuromuscular Disorders, 2002
- Vertebrate tropomyosin: distribution, properties and functionJournal of Muscle Research and Cell Motility, 2001
- Physiological consequences of tropomyosin mutations associated with cardiac and skeletal myopathiesJournal of Molecular Medicine, 2000
- Regulation of Contraction in Striated MusclePhysiological Reviews, 2000
- Clinical analysis of a variant of Freeman-Sheldon syndrome (DA2B)American Journal of Medical Genetics, 1998
- Molecular diversity of myofibrillar proteins: gene regulation and functional significancePhysiological Reviews, 1996
- Mitochondrial encephalomyopathies in childhood. I. Biochemical and morphologic investigationsThe Journal of Pediatrics, 1991